Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
about
"Stormy waters ahead": global emergence of carbapenemasesEmpiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment optionsTigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-AnalysisMethicillin-resistant Staphylococcus aureus therapy: past, present, and futureTreatment of Gram-positive infections in critically ill patientsTigecycline : a critical safety reviewTigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting.High dose of tigecycline for extremely resistant Gram-negative pneumonia: yes, we can.Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomesCarbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patientsIn vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcyclineCommon harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indicationSafety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010Activity of Fosfomycin against Extended-Spectrum-β-Lactamase-Producing Uropathogens in Patients in the Community and Hospitalized PatientsTigecycline treatment of urinary tract infection and prostatitis: case report and literature review.Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobials.Excess deaths associated with tigecycline after approval based on noninferiority trials.Efflux in the Oral Metagenome: The Discovery of a Novel Tetracycline and Tigecycline ABC Transporter.Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Intrinsic and acquired resistance mechanisms in enterococcus.Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.Efficacy and safety of tigecycline: a systematic review and meta-analysis.When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.Surveillance and management of multidrug-resistant microorganisms.Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.The hospitalist perspective on treatment of community-acquired bacterial pneumonia.Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?Current and emerging drugs for acute bacterial skin and skin structure infections: an update.Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.
P2860
Q21131125-34268792-9500-49AD-8F48-5FE67972E25DQ21146707-01BCC254-9DB5-4FDA-BB36-B400A3FF7FC0Q26764796-ADA9D4F9-9583-459E-BFBE-7957CEB66D91Q27011165-50F65FE2-ABCA-4475-8955-9C3F9477864CQ27015976-43F0D5F7-66CA-421F-93B4-2B4A1B38A5C4Q28254593-FA6B91BF-6FB4-49E4-978E-2E016441C6D2Q33770721-E26B14ED-F01C-496E-B0A1-E4FF56E98360Q33822682-9B262872-8BFA-4C52-B580-AA47B260A580Q33892585-3C72B1C3-1440-4EE9-A200-D53A14F79076Q34320945-DA299E24-5455-4743-B04B-F9A8B4F6A54AQ34336456-AC1F6980-7868-4466-9FA3-7E8E968D4E0EQ34389235-C2ACBC3D-9B94-4C9E-8C4C-59CA559ADDCEQ34448330-A966D5CD-6339-4B28-85BC-0CE2F8E5AFBFQ34503844-13E4F1A4-2863-444A-83B5-4DBA27B5D855Q35101242-737D5222-3169-4438-A7AA-EC19C1BD41FFQ35542062-B7051E33-A39F-4E1F-B2AD-7BA8B65B1195Q35806428-C1CEDBCA-94B2-4569-9E72-2B66DC84F959Q35848981-2C7A94F1-71AF-41E5-B8FA-5D4F7A488A1DQ36048290-C50305F5-0036-4110-AA91-59DA66C5FBB5Q36115620-5B614A32-8C68-4B98-ABDC-B2F665A91BDCQ36115632-6535B7F3-0FC4-411F-97CA-75D9FD567E63Q36229936-2F6FF89A-83A4-4A90-AB65-95BB26F058DDQ36281234-671F1E44-AF69-44C0-8CF8-394AAD9A1E37Q36362547-BA941392-8F23-4A3A-A868-AD27843BBC5DQ36672253-1933491F-A531-492F-9371-B7725F82F955Q36933389-A76ADE06-A19A-4B03-97B8-3A3D5977180BQ37197429-250D41B0-37BD-4148-92FF-EFFB3BDB9C26Q37377897-6DF57282-B7BB-4C67-B04C-86A2ECDC30B1Q37713697-7C8EDFB3-1CEB-481E-8EDA-EEFF5817FDC1Q37891606-D80BFC53-3F1E-4D8D-9E50-FD7A7B616BB1Q37907967-0A44DFC6-D99E-487D-AD19-DC9EAEA48553Q37912231-727E3803-5132-4F7E-ACB9-33479E9E7178Q37949553-0869F7A6-69F5-426F-9CA0-88B8C37C311CQ37970757-03F00380-2649-45D3-AD14-9AF0DC134E82Q38115356-1B4950DA-E8AC-4527-99FD-38A7C0339114Q38200827-570A9404-1AC5-4588-98EC-D6C9B2F51E2DQ38231648-30034D22-3E3B-429F-84A0-85FCB43267A1Q38242081-5C292362-393B-4F78-AD43-6A66E179F01FQ38325217-EB081DB6-57FD-4F23-9DA5-4DD4F6815626Q38384662-ED5A643A-433F-4F6E-A1AC-3BA9F71219EE
P2860
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Systematic review and meta-ana ...... eatment of infectious disease.
@ast
Systematic review and meta-ana ...... eatment of infectious disease.
@en
type
label
Systematic review and meta-ana ...... eatment of infectious disease.
@ast
Systematic review and meta-ana ...... eatment of infectious disease.
@en
prefLabel
Systematic review and meta-ana ...... eatment of infectious disease.
@ast
Systematic review and meta-ana ...... eatment of infectious disease.
@en
P2093
P2860
P31
P356
P1476
Systematic review and meta-ana ...... eatment of infectious disease.
@en
P2093
P2860
P304
P356
10.1128/AAC.01402-10
P407
P577
2010-12-20T00:00:00Z